Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma

British Journal of Cancer

Volumn 75, Issue 4, 1997, Pages 523-527

  Bjorkqvist A M ^a   Tammilehto, L ^b   Anttila, S ^b   Mattson, K ^c   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Comparative genomic hybridization; DNA sequence; Gain; Loss; Mesothelioma

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 9P; CLINICAL ARTICLE; DNA HYBRIDIZATION; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE DELETION; HUMAN; HUMAN TISSUE; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

EID: 0031059844     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.91     Document Type: Article

References (39)

1. Antman K, Shemin R, Ryan L, Klegar K, Osteen R, Herman T, Lederman G and Corson J (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985. J Clin Oncol 6: 147-153
2. Cairns P, Shaw ME and Knowles MA (1993) Initiation of bladder cancer may involve deletion of a tumor suppressor gene on chromosome 9. Oncogene 8: 1083-1085
3. Center R, Lukeis R, Dietzsch E, Gillespie M and Garson OM (1993) Molecular deletion of 9p sequences in non-small cell lung cancer and malignant mesothelioma. Genes Chrom Cancer 7: 47-53
4. Cheng JQ, Jhanwar SC, Lu YY and Testa JR (1993) Homozygous deletion within chromosome region 9p21-p22 in human malignant mesotheliomas. Cancer Res 53: 4761-4764
5. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee W-C, Altomare DA, Nobori T, Olopade OI, Buckler AJ and Tesla JR (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res. 54: 5547-5551
6. Diaz MO, Rubin CM, Harden A, Ziemen S, Larson RA, Le Beau MM and Rowley JD (1990) Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med 322: 77-82
7. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
8. Flejter WL, Li FP, Antman KH and Testa JR (1989) Recurring loss involving chromosomes 1, 3 and 22 in malignant mesothelioma: possible sites of tumor suppressor genes. Genes Chrom Cancer 1: 148-154
9. Fountain JW, Karayiorgou M, Ernstoff MS, Kirkwood JM, Vlock DR, Titus-Ernstoff L, Bouchard B, Vijaysaradhi S, Houghton AN, Lahti J, Kidd VJ, Housman DE and Dracopoli NC (1992) Homozygous deletion within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89: 10557-10561
10. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW and Harris CC (1987) Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 47: 6180-6184
11. Hagemeijer A, Versnel MA, Van Drunen E, Moret M, Bouts MJ, van der Kwast, Th H and Hoogsteden HC (1990) Cytogenetic analysis of mesothelioma. Cancer Genet Cytogenet 47: 1-28
12. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K and Linnainmaa K (1995) Inherited GSTM 1 and NAT2 as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 55:2981-2983
13. Isobe H, Sridhar KS, Doria R, Cohen F, Raub WA, Saldana M and Krishan A (1995) Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma. Cytometry 19: 86-91
14. Isola J, DeVries S, Chu L, Ghazvini S and Waldman F (1994) Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples. Am J Pathol 145: 1301-1308
15. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821
16. Kallioniemi A, Kallioniemi O-P, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW and Waldman FM (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-21560
17. Kallioniemi A, Kallioniemi O-P, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P and Waldman F (1995) Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chrom Cancer 12: 213-219
18. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chrom Cancer 10: 231-243
19. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day III RS, Johnson BE and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
20. Kivipensas P, Björkqvist A-M, Karhu R, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Kallioniemi O-P and Knuutila S (1996) Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet 89: 7-13
21. Knudson AG (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437-1443
22. Lynch HT, Katz D and Markvicka SE (1985) Familial mesothelioma: review and family study. Cancer Genet Cytogenet 15: 25-35
23. Mead LJ, Gillespie MT, Irving LB and Campbell LJ (1994) Homozygous and hemizygous deletions of 9p centromeric to the interferon genes in lung cancer. Cancer Res 54: 2307-2309
24. Meloni AM, Stephenson CF, Li FP and Sandberg AA (1992) del(6q) as a possible primary change in malignant mesothelioma. Cancer Genet Cytogenet 59: 57-61
25. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI and Harris CC (1992) p53 and Kirsten-ras mutations in human mesothelioma cell lines. Cancer Res 52: 2610-2615
26. Monni O, Joensuu H, Franssila K and Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma - comparative genomic hybridization study. Blood 87: 5269-5278
27. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin BI, Harris CC, Tuomi T, Vanhala E, Mattson K and Linnainmaa K (1990) Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11: 673-681
28. Popescu NC, Chahinian AP and DiPaolo JA (1988) Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res 48: 142-147
29. Pyrhönen S, Laasonen A, Tammilehto L, Rautonen J, Anttila S, Mattson K and Holsti LR (1991) Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma. Eur J Cancer 27: 197-200
30. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schröck E, Latham C, Blegen H, Zetterberg A, Cremer T and Auer G (1995) Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55: 5415-5423
31. Segers K, Ramael M, Singh SK, Van Daele A, Weyler J and Van Marck E (1995) Detection of numerical chromosomal aberrations in paraffin-embedded malignant pleural mesothelioma by non-isotopic in situ hybridization. J Pathol 175: 219-226
32. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM and Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53: 4349-1355
33. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K and Knuutila S (1989) Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60: 618-626
34. Tiainen M, Hopman A, Moesker O, Ramaekers F, Wessman M, Laasonen A, Pyrhönen S, Tammilehto L, Mattson K and Knuutila S (1992) Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. A comparison to conventional karyotyping and flow cytometric studies. Cancer Genet Cytogenet 62: 171-179
35. Van der Meeren A, Seddon MB, Kispert J, Harris CC and Gerwin BI (1993a) Lack of expression of the retinoblastoma gene is not frequently involved in the genesis of human mesothelioma. Eur Respir Rev 3: 177-179
36. Van der Meeren A, Seddon MB, Betsholtz CA, Lechner JF and Gerwin BI (1993b) Platelet-derived growth factor A-chain overexpression is associated with tumorigenic conversion of human mesothelial cells. Eur Respir Rev 3: 180-185
37. Wagner JC, Sleggs CA and Marchand P (1960) Diffuse pleural mesotheliomas and asbestos exposure in the Northwestern Cape Province. Br J Ind Med 17: 260-271
38. Xiao S, Li D, Vijg J, Sugarbaker DJ, Corson JM and Fletcher JA (1995) Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene 11: 511-515
39. Zeiger MA, Gnarra JR, Zbar B, Linehan WM and Pass HI (1994) Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chrom Cancer 11: 15-20